{"transactions":[{"id":769905,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-05-20T23:51:59.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":false,"shares":2206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty percent (25%) of the grant of 35,294 Restricted Stock Units vested upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of twelve (12) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the fourth anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Twenty percent (25%) of the grant of 35,294 Restricted Stock Units vested upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of twelve (12) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":24265,"derivative":{"underlying":"Common Stock","underlying_shares":2206},"source":{"system":"sec-edgar","filing":"0001683168-26-004192","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000168316826004192/ownership.xml","form_type":"4"}},{"id":769904,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-20T23:51:59.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":true,"shares":2206,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of common stock."}],"balance_after":11030,"source":{"system":"sec-edgar","filing":"0001683168-26-004192","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000168316826004192/ownership.xml","form_type":"4"}},{"id":890566,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-20T21:19:42.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":false,"shares":8824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty percent (25%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of twelve (12) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the fourth anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Twenty percent (25%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of twelve (12) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":26471,"derivative":{"underlying":"Common Stock","underlying_shares":26471},"source":{"system":"sec-edgar","filing":"0001683168-26-001220","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000168316826001220/ownership.xml","form_type":"4"}},{"id":890565,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-20T21:19:42.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":8824,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."}],"balance_after":8824,"source":{"system":"sec-edgar","filing":"0001683168-26-001220","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000168316826001220/ownership.xml","form_type":"4"}},{"id":1057736,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Purchase)","published_at":"2025-08-23T00:00:27.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Amendment No. 1 (\"Form 4/A\") to the Form 4 filed by the reporting person on August 8, 2025 (the \"Original Form 4\") is being filed to correct an administrative error, resulting in the incorrect vesting schedule for the stock option being included in the Original Form 4. As reflected in this Form 4/A, the stock option vests as follows: (i) 25% upon the first anniversary of the grant date, and (ii) the remaining 75% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date."}],"balance_after":45000,"derivative":{"exercise_price":3.32,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001683168-25-006429","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000168316825006429/ownership.xml","form_type":"4/A","original_submission_date":"2025-08-08"}},{"id":1071316,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Purchase)","published_at":"2025-08-08T22:45:52.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as follows: (i) 50% upon the first anniversary of the grant date, and (ii) the remaining 50% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date."}],"balance_after":45000,"derivative":{"exercise_price":3.32,"expiration_date":"2035-08-05","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001683168-25-005834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000168316825005834/ownership.xml","form_type":"4"}},{"id":1249416,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-24T22:01:03.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 600,000 restricted stock units granted to the Reporting Person outside of the Issuer's Amended and Restated 2021 Equity Incentive Plan (the \"Plan\"), in connection with, and as a material inducement to, the hiring and appointment of the Reporting Person as Chief Operating Officer of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty percent (25%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of twelve (12) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":600000,"derivative":{"expiration_date":"2035-02-17","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001683168-25-001207","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000168316825001207/ownership.xml","form_type":"4"}},{"id":2614733,"issuer":{"id":128906,"kind":"organization","name":"Statera Biopharma, Inc.","symbol":"STAB"},"owners":[{"id":45650,"kind":"person","name":"Handley Michael K","position":1,"cik":"0001451334","reported_name":"Handley Michael K","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.005 per share","published_at":"2021-08-04T23:00:16.000Z","date":"2021-07-27","kind":"grant","acquired":true,"shares":296609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares received pursuant to an Agreement and Plan of Merger (\"merger agreement\"), entered into by Cytocom Inc. (\"Old Cytocom\") and Cleveland BioLabs, Inc (\"New Cytocom\" or \"Issuer\"). Per the \"merger agreement\", each share of Old Cytocom (i) common stock, (ii) preferred stock that was not converted into Old Cytocom common stock immediately prior to the effective time of the Merger, and (iii) each vested restricted stock unit of Old Cytocom (excluding, in each case, dissenting shares and shares held in treasury) converted into the right to receive a number of shares of New Cytocom common stock based on an exchange formula set forth in the merger agreement (which we refer to as the \"merger consideration\")."}],"balance_after":296609,"source":{"system":"sec-edgar","filing":"0001437749-21-018563","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451334/000143774921018563/rdgdoc.xml","form_type":"4"}}]}